Search

Search Constraints

You searched for: Author/Creator Donehower, Ross

Search Results

1. A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab‐Paclitaxel and Gemcitabine in Advanced Solid Tumors. (16th August 2018)

2. Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017. (28th January 2021)

3. Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer. (February 2016)

4. Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer. (21st June 2017)